Gastric Outlet Obstruction
20
5
6
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.0%
1 terminated out of 20 trials
90.0%
+3.5% vs benchmark
5%
1 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (20)
AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE
Prospective Registry Of Therapeutic EndoscopiC ulTrasound
EUS-GE vs ES for Palliation of Gastric Outlet Obstruction
Management of Malignant Gastric Outlet Obstruction Between Surgery and Endoscopy
GT Metabolic Magnet System in Adults With Gastrointestinal Disorders
Clinical Trial of EPASS With Hot AXIOS System
Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass
Novel Balloon-Assisted vs Direct Technique in EUS-Guided Gastroenterostomy
Randomized Trial of EUS-guided Gastrojejunostomy and Surgical Gastrojejunostomy in Gastric Outlet Obstruction
Enteral Anastomosis for the Treatment of Gastric Outlet Obstruction: A Randomized Controlled Study Comparing Endoscopic Versus Surgical Gastrojejunostomy
EPASS Versus Uncovered Duodenal Stent for Unresectable Malignant Gastric Outlet Obstruction.
Endoscopic Surgery for Gastrointestinal Disorders: A Multicenter Registry Study
EUS-guided Versus Laparoscopic Gastrojejunostomy for Malignant Gastric Outlet Obstruction
EUS - Guided Balloon-occluded Gastrojejunostomy Bypass
Nasobiliary Drain Assisted EUS-guided Gastroenterostomies in Unresectable Malignant Gastric Outlet Obstruction
Magnetic Anastomosis Device Relief of Malignant Gastric Outlet Obstruction
Gastric Outlet Obstructions Tailored Covered Stents for GOO
RCT: STARR vs Biofeedback
ComVi and D-type Stent in Malignant GOO
EVOLUTION® Duodenal Stent for Duodenal or Gastric Outlet Obstruction Caused by Malignant Neoplasms